Illumina Other Stockholder Equity from 2010 to 2024

ILMN Stock  USD 113.72  1.00  0.87%   
Illumina Other Stockholder Equity yearly trend continues to be very stable with very little volatility. Other Stockholder Equity is likely to grow to about 6.1 B this year. During the period from 2010 to 2024, Illumina Other Stockholder Equity quarterly data regression pattern had range of 6.1 B and standard deviation of  2,276,824,239. View All Fundamentals
 
Other Stockholder Equity  
First Reported
2000-03-31
Previous Quarter
5.8 B
Current Value
5.7 B
Quarterly Volatility
1.7 B
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Illumina financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Illumina's main balance sheet or income statement drivers, such as Depreciation And Amortization of 453.6 M, Interest Expense of 60.3 M or Total Revenue of 4.7 B, as well as many indicators such as Price To Sales Ratio of 4.64, Dividend Yield of 0.0 or PTB Ratio of 5.47. Illumina financial statements analysis is a perfect complement when working with Illumina Valuation or Volatility modules.
  
Check out the analysis of Illumina Correlation against competitors.
To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.

Latest Illumina's Other Stockholder Equity Growth Pattern

Below is the plot of the Other Stockholder Equity of Illumina over the last few years. It is Illumina's Other Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Illumina's overall financial position and show how it may be relating to other accounts over time.
Other Stockholder Equity10 Years Trend
Slightly volatile
   Other Stockholder Equity   
       Timeline  

Illumina Other Stockholder Equity Regression Statistics

Arithmetic Mean2,037,658,282
Coefficient Of Variation111.74
Mean Deviation1,913,535,583
Median900,867,000
Standard Deviation2,276,824,239
Sample Variance5183928.6T
Range6.1B
R-Value0.73
Mean Square Error2644463.5T
R-Squared0.53
Significance0
Slope369,347,759
Total Sum of Squares72575000.6T

Illumina Other Stockholder Equity History

20246.1 B
20235.8 B
20225.5 B
20215.2 B
2020-33 M
2019539 M
2018761 M

About Illumina Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Illumina income statement, its balance sheet, and the statement of cash flows. Illumina investors use historical funamental indicators, such as Illumina's Other Stockholder Equity, to determine how well the company is positioned to perform in the future. Although Illumina investors may use each financial statement separately, they are all related. The changes in Illumina's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Illumina's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Illumina Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Illumina. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Stockholder Equity5.8 B6.1 B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Additional Information and Resources on Investing in Illumina Stock

When determining whether Illumina offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Illumina's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Illumina Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Illumina Stock:
Check out the analysis of Illumina Correlation against competitors.
To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Illumina. If investors know Illumina will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Illumina listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.96)
Earnings Share
(8.14)
Revenue Per Share
28.392
Quarterly Revenue Growth
(0.01)
Return On Assets
(0.01)
The market value of Illumina is measured differently than its book value, which is the value of Illumina that is recorded on the company's balance sheet. Investors also form their own opinion of Illumina's value that differs from its market value or its book value, called intrinsic value, which is Illumina's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Illumina's market value can be influenced by many factors that don't directly affect Illumina's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Illumina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.